~~<i id='3B120B24FE'><strike id='3B120B24FE'><tt id='3B120B24FE'><pre id='3B120B24FE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：comprehensive 2025-10-02 19:15:18 - browse：33

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Live blog: Hearing on CRISPR

hotspot

focus

hotspot

focus

Wikipedia

entertainment

1:18AtourguidefansherselfwhileworkinginTimesSquareastemperaturesrise,July27,2023,inNewYorkCity.JohnM

WSS

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

After John Oliver segment, STAT readers share their opioid

Infant mortality in U.S. rose last year for first time in decades: CDC

Some of the ways extreme heat will change life as we know it

Lung cancer screening guidelines updated for cigarette smokers

What is microchimerism and how does it affect maternal health?

leisure time

entertainment

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Prime Medicine says its gene editing passes test in monkeys

Bright Health sells Medicare Advantage business to Molina

Medicare must police algorithms in Medicare Advantage, Dems say

Medicare details structure of new drug price negotiation program

Novo acquires Inversago for up to $1 billion

BioMarin wins approval for gene therapy to treat hemophilia A

TB outbreak tied to bone grafts underscores testing shortcomings

Affirmative action in medical school literally saved lives

Explaining an after

focus

Life sciences investors close nearly $6 billion in new funds

Genentech weighs delaying cancer therapy after drug pricing law

All of Us, NIH's precision medicine initiative, gets a big boost

Gene therapy’s promise and the high cost of hope

Who are the detained American citizens released from prison in Iran?

Timeline: Special counsel's investigation into Trump's handling of classified documents

hotspot

focus

Wikipedia

entertainment